Literature DB >> 32619698

Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease.

Key-Hwan Lim1, Sumin Yang1, Sung-Hyun Kim1, Jae-Yeol Joo2.   

Abstract

Entities:  

Keywords:  Ace2; Alzheimer's disease; Genome-wide association study; Sars-cov-2

Mesh：

Substances：

Year:  2020        PMID： 32619698     DOI： 10.1016/j.jinf.2020.06.072

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  15 in total

1.  SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer's disease.

Authors:  Walter J Lukiw
Journal:  J Alzheimers Dis Parkinsonism       Date:  2021-05-10

Review 2.  COVID-19 and Alzheimer's Disease.

Authors:  Marcello Ciaccio; Bruna Lo Sasso; Concetta Scazzone; Caterina Maria Gambino; Anna Maria Ciaccio; Giulia Bivona; Tommaso Piccoli; Rosaria Vincenza Giglio; Luisa Agnello
Journal:  Brain Sci       Date:  2021-02-27

3.  Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease.

Authors:  Qiyue Ding; Nataliia V Shults; Sergiy G Gychka; Brent T Harris; Yuichiro J Suzuki
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

4.  Alzheimer's and Parkinson's Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study.

Authors:  Yizhou Yu; Marco Travaglio; Rebeka Popovic; Nuno Santos Leal; Luis Miguel Martins
Journal:  Geriatrics (Basel)       Date:  2021-01-26

5.  COVID-19 related outcomes among individuals with neurodegenerative diseases: a cohort analysis in the UK biobank.

Authors:  Yihan Hu; Huazhen Yang; Can Hou; Wenwen Chen; Hanyue Zhang; Zhiye Ying; Yao Hu; Yajing Sun; Yuanyuan Qu; Maria Feychting; Unnur Valdimarsdottir; Huan Song; Fang Fang
Journal:  BMC Neurol       Date:  2022-01-07       Impact factor: 2.903

Review 6.  Alzheimer's disease in elderly COVID-19 patients: potential mechanisms and preventive measures.

Authors:  Haili Wang; Juan Lu; Xia Zhao; Rongyin Qin; Kangping Song; Yao Xu; Jun Zhang; Yingzhu Chen
Journal:  Neurol Sci       Date:  2021-09-22       Impact factor: 3.307

Review 7.  Healthy Immunity on Preventive Medicine for Combating COVID-19.

Authors:  Pulak R Manna; Zackery C Gray; P Hemachandra Reddy
Journal:  Nutrients       Date:  2022-02-27       Impact factor: 5.717

8.  Mortality Risk within 14 Days after Coronavirus Disease 2019 Diagnosis in Dementia Patients: A Nationwide Analysis.

Authors:  Yi-Jun Kim; Yongho Jee; Sholhui Park; Eun-Hee Ha; Inho Jo; Hyang Woon Lee; Myung Seon Song
Journal:  Dement Geriatr Cogn Disord       Date:  2021-12-02       Impact factor: 2.959

9.  The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology.

Authors:  Huan Cui; Si Su; Yan Cao; Chao Ma; Wenying Qiu
Journal:  Front Cell Dev Biol       Date:  2021-06-25

Review 10.  The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.

Authors:  Hamidreza Zalpoor; Abdullatif Akbari; Azam Samei; Razieh Forghaniesfidvajani; Monireh Kamali; Azadeh Afzalnia; Shirin Manshouri; Fatemeh Heidari; Majid Pornour; Majid Khoshmirsafa; Hossein Aazami; Farhad Seif
Journal:  Cell Mol Biol Lett       Date:  2022-02-02       Impact factor: 5.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.